Leap Therapeutics Inc Sustainability Reports
The company operates as a biopharmaceutical enterprise that acquires and develops targeted therapies and immuno-oncology therapeutics for cancer treatment. It also administers a digital asset treasury strategy focused on Zcash.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300T31SMMJ2DDLI13
FIGI: BBG00DQ929Z3
No reports are currently available in our catalogue.